Transcatheter valve-in-valve overexpansion for treating a large dysfunctional tricuspid bioprosthesis

Asmarats, Lluís; Houde, Christine; Pasian, Sergio; Rodés‐Cabau, Josep

doi:10.1093/icvts/ivx345

Cited by 4 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The selection of type of prosthetic valve is another important issue, so that the availability of transcatheter valve-in-valve replacement can change the trade-offs between mechanical and bioprosthetic valves [3]. Tricuspid valve-in-valve procedure was shown to be technically feasible in a number of studies in patients with a wide range of valve size [13,28]. This will be more interesting when we consider the relatively short average time to thrombosis and a high recurrence rate in our study together with the data derived from former studies indicating mean reoperation time of 44.2 months for mechanical prosthesis [29].…”

Section: Discussionmentioning

confidence: 99%

Management and Clinical Outcomes in Patients with Mechanical Tricuspid Valve Thrombosis

Shojaeifard

Sarrafirad²,

Erami

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: The incidence of prosthetic tricuspid valve (TV) thrombosis is the highest among heart valves. It can lead to high morbidity and mortality without proper treatment. In this study we sought to report the management and clinical outcomes of patients with mechanical TV thrombosis. Methods: In in a retrospective single-center study, all patients with mechanical TV thrombosis were evaluated from 2006 to 2017. The data on baseline characteristics, management of mechanical TV thrombosis, and the rates of adverse events during follow-up period were assessed. Results: A total of 67 episodes of mechanical TV thrombosis in 42 patients were observed. The mean age of patients was 45.5±14.3 years (19 to 77), and overall two-thirds were female. Thrombolytic therapy (TT) was used in 41 (61.1%), anticoagulant intensification in 15 (22.3%), and surgery as first approach in 11 (16.4%) episodes; subsequently, surgery as the final approach was implemented in 20 (29.8%) episodes. There were a total of 2 (2.98%) in-hospital deaths. Moreover, 2 (4.87%) episodes of retroperitoneal hematoma and 1(2.43%) episode of non-hemorrhagic thalamic infarct in TT group, and 1 (5%) episode of non-hemorrhagic stroke following surgery were developed. The rates of freedom from recurrent thrombosis were 84%, 61%, and 21% at the end of 2, 4, and 10 years, respectively. Survival rates and freedom from chronic valve dysfunction was 93%, 82%, and 75% after 1, 4, and 10 years. Conclusions: The recurrent thrombosis requiring intervention is a major complication of mechanical TV, which underscores individual-approached therapy and close follow-up to improve outcome.

show abstract

Section: Discussionmentioning

confidence: 99%

Management and Clinical Outcomes in Patients with Mechanical Tricuspid Valve Thrombosis

Shojaeifard

Sarrafirad²,

Erami

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…14,28 This will be more interesting when we consider the relatively short average time to thrombosis and a high recurrence rate in our study together with the data derived from former studies indicating a mean reoperation time of 44.2 months for mechanical prosthesis. 29…”

Section: Recurrent Thrombosismentioning

confidence: 99%

Mechanical tricuspid valve thrombosis: A midterm follow‐up study

Shojaeifard

Omidi

Erami

et al. 2022

Journal of Cardiac Surgery

View full text Add to dashboard Cite

Background: The incidence of prosthetic tricuspid valve (TV) thrombosis is the highest among heart valves. It can lead to high morbidity and mortality without proper treatment. In this study, we sought to report the management and clinical outcomes of patients with mechanical TV thrombosis.Methods: The current study was conducted in Rajaei Heart Center on 42 patients with mechanical TV thrombosis from 2006 to 2017. The baseline characteristics and the rates of adverse events during the follow-up period were assessed.Results: A total of 67 episodes of mechanical TV thrombosis in 42 patients were observed. The mean age of patients was 45.5 ± 14.3 years (19-77), and overall two-thirds were female. Thrombolytic therapy was used in 41 (61.1%), anticoagulant intensification in 16 (23.9%), and surgery as the first approach in 10 (14.9%) episodes; subsequently, surgery as the final approach was implemented in 20 (29.8%) episodes. In-hospital mortality occurred in two (2.98%) patients. The rates of freedom from recurrent thrombosis were 84%, 61%, and 21% at the end of 1, 4, and 10 years, respectively. Survival rates and freedom from chronic valve dysfunction were 93%, 82%, and 75% after 1, 4, and 10 years. Conclusions:The results of the present study showed that recurrent thrombosis requiring intervention is a major complication of mechanical TV, which underscores individual-approached therapy and close follow-up.

show abstract

Preliminary Study of a Degenerated Tricuspid Bioprosthetic Valve Implanted via Transcatheter Valve-in-Valve Implantation Guided by 3-Dimensional Printing

Mao,

Ma,

Zhai

et al. 2024

CJC Open

View full text Add to dashboard Cite

Transcatheter valve-in-valve overexpansion for treating a large dysfunctional tricuspid bioprosthesis

Cited by 4 publications

References 5 publications

Management and Clinical Outcomes in Patients with Mechanical Tricuspid Valve Thrombosis

Management and Clinical Outcomes in Patients with Mechanical Tricuspid Valve Thrombosis

Mechanical tricuspid valve thrombosis: A midterm follow‐up study

Preliminary Study of a Degenerated Tricuspid Bioprosthetic Valve Implanted via Transcatheter Valve-in-Valve Implantation Guided by 3-Dimensional Printing

Contact Info

Product

Resources

About